N-methyl pyridinium methyl sulfate

We are N-methyl pyridinium methyl sulfate CAS:37943-43-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 37943-43-4
Product Name: N-methyl pyridinium methyl sulfate
Other Name:
N-methyl pyridinium methyl sulfate
 
Molecular Formula: C7H11NO4S
Molecular Weight: 205.23200
Exact Mass: 205.04100
PSA: 78.69000
LogP: 0.68490
 
Specification
Appearance: Solid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Paraquat CAS: 4685-14-7.
Be used as pesticide intermediate, mainly used to synthesize herbicide Paraquat.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

N-methyl pyridinium methyl sulfate


Related News: The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).5-chloro-3-methylpyridin-2-amine Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.Phenetole CAS:103-73-1 The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).5-piridin-2-il-1H-piridin-2-ona CAS:381233-78-9 The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).

Related Products
Product Name
2-Bromo-4-cyanopyridine View Details
Methyl 7-(3-hydroxy-5-oxo-1-cyclopenten-1-yl)heptanoate View Details
5-(Trifluoromethyl)indole View Details
Ethyl 4-bromobutyrate manufacturer trimethoxy(2-trimethoxysilylethyl)silane manufacturer L-alpha-Amino-n-butyric acid manufacturer 3-Amino-6-bromopyridine manufacturer N-(2-Hydroxyethyl)-3,4-Methylenedioxyaniline Hydrochloride manufacturer